Gc Labs And Two Clinical Diagnostic Companies Enter The Collaboration For The New Lab Testing Service
Gc Labs (Ceo, Dr. Eun-Hee Lee), The Leading Clinical Diagnostics Company In Korea, Today Announced The New Lab Testing Service Agreement With Two Partners: Bio Lab In Bahrain And Biotrust In Cambodia.Since The Start Of Year 2022, Gc Labs Has Actively Established Business Partnership With Global Diagnostics Companies.In January, Gc Labs Officially Signed The Lab Testing Service Agreement With Two Clinical Diagnostic Companies In Middle East: Contract Extension With Life Dx To Expand Its Sales Area From Uae To Saudi, Oman, And Egypt, And New Agreement With Pml, Based In Jordan.Subsequently, Gc Labs Has Added Two More Partnerships, Accelerating The Expansion In Global Partnership. By Signing The Agreement, Gc Labs Is Expected To Provide Both Companies With Testing Service And Expand Its Footprint With A Solid Presence In Asia And Middle East.E.H. Lee From Gc Labs Said

Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!